{"ok":true,"trend":{"id":672590,"platform":"news","region":"global","key":"cell therapy weekly: laverock therapeutics expands to in vivo car-t and genetic medicine","title":"Cell Therapy Weekly: Laverock Therapeutics Expands to In Vivo CAR-T and Genetic Medicine","url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNajQ4bjdmZzVoWVZtYkJWa1dLalRIbnc1VVU3Nnd4empZMUlNLW5reDN1LUV1S3F3ckpqNTNocTJUbVh4RnNpSktyVzhPSWkxbE5pb19nQ1RnMUhpLVNnYUFsa1E4eFpjelR0aExGWVA3WTJaMm9wUEg0bFlNNE5aYTR6R0xyTDF0NWQxYzZMNC1wVWU4eHRrN2R2cldCYTFoOUp4S01yYW1fZmNma0dkX2tpZ3o?oc=5","first_seen":"2026-10-02T00:48:21.488750Z","last_seen":"2026-10-02T17:18:32.688069Z","last_rank":33,"peak_rank":6,"last_volume":null,"peak_volume":0,"seen_count":13,"score":0.571875,"category_hint":"medicine","section":"health","category":"medicine","summary":"Laverock Therapeutics announced an expansion of its work into in vivo CAR-T cell therapy and broader genetic medicine, according to Cell Therapy Weekly coverage. The move signals the company's ambition to move beyond ex vivo approaches and broaden its therapeutic pipeline, drawing attention from the regenerative medicine and cell therapy community.","why":"The biotech sector is closely watching companies expanding CAR-T technology toward in vivo delivery, a potential shift in how cell therapies are made.","tone":"neutral","entities":["Laverock Therapeutics","RegMedNet"],"summarized_at":"2026-10-02T18:57:03.913522Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"RegMedNet","published":"Fri, 02 Oct 2026 00:03:27 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Laverock Therapeutics Expands into In Vivo CAR-T and Genetic Medicine","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-10-02T00:48:21.488750Z","rank":8,"volume":null},{"captured_at":"2026-10-02T02:10:41.304274Z","rank":6,"volume":null},{"captured_at":"2026-10-02T03:36:10.813869Z","rank":8,"volume":null},{"captured_at":"2026-10-02T04:58:49.542686Z","rank":14,"volume":null},{"captured_at":"2026-10-02T06:20:51.072369Z","rank":14,"volume":null},{"captured_at":"2026-10-02T07:43:32.976550Z","rank":19,"volume":null},{"captured_at":"2026-10-02T09:05:52.360127Z","rank":25,"volume":null},{"captured_at":"2026-10-02T10:28:11.964561Z","rank":17,"volume":null},{"captured_at":"2026-10-02T11:50:15.567101Z","rank":13,"volume":null},{"captured_at":"2026-10-02T13:12:11.882320Z","rank":13,"volume":null},{"captured_at":"2026-10-02T14:34:35.057330Z","rank":15,"volume":null},{"captured_at":"2026-10-02T15:56:33.379918Z","rank":18,"volume":null},{"captured_at":"2026-10-02T17:18:32.688069Z","rank":33,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNajQ4bjdmZzVoWVZtYkJWa1dLalRIbnc1VVU3Nnd4empZMUlNLW5reDN1LUV1S3F3ckpqNTNocTJUbVh4RnNpSktyVzhPSWkxbE5pb19nQ1RnMUhpLVNnYUFsa1E4eFpjelR0aExGWVA3WTJaMm9wUEg0bFlNNE5aYTR6R0xyTDF0NWQxYzZMNC1wVWU4eHRrN2R2cldCYTFoOUp4S01yYW1fZmNma0dkX2tpZ3o?oc=5","author":"RegMedNet","title":"Cell Therapy Weekly: Laverock Therapeutics Expands to In Vivo CAR-T and Genetic Medicine","snippet":null,"posted_at":"2026-10-02T00:03:27Z","likes":null}],"elsewhere":[],"window":"7d"}}